Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Triamcinolone 💬[1] Triamcinolone (Naltrexone)[4] Kenalog; Naltrexone; Triamcinolone; Triamcinolone Acetonide[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[11] 35, 46, 53, 56, 70, 90, 96, 107, 162, 226, 298 💬
2 Naltrexone 💬
(Naltrexone (USAN/INN))		[1] Naltrexone (Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release)[2] Naltrexone; Naltrexone hydrochloride[3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[12] 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
3 Bupropion 💬[1] Bupropion (Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release)[2] Bupropion; Bupropion Hydrochloride[2] SLC6A2,
SLC6A3 💬 		[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[5] 8, 18, 21, 96, 171 💬